Oberweis Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-46,800
| Closed | -$8.44M | – | 199 |
|
|
2025
Q1 | $8.44M | Hold |
46,800
| – | – | 0.42% | 85 |
|
|
2024
Q4 | $7.33M | Hold |
46,800
| – | – | 0.35% | 110 |
|
|
2024
Q3 | $8.52M | Buy |
46,800
+4,200
| +10% | +$765K | 0.44% | 88 |
|
|
2024
Q2 | $7.82M | Buy |
42,600
+6,900
| +19% | +$1.27M | 0.48% | 78 |
|
|
2024
Q1 | $6.35M | Buy |
+35,700
| New | +$6.35M | 0.46% | 87 |
|